- Home
- UBXG vs HOTH Comparison
UBXG vs HOTH Comparison
Compare UBXG & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBXG
- HOTH
- Stock Information
- Founded
- UBXG 2018
- HOTH 2017
- Country
- UBXG China
- HOTH United States
- Employees
- UBXG N/A
- HOTH N/A
- Industry
- UBXG
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- UBXG
- HOTH Health Care
- Exchange
- UBXG Nasdaq
- HOTH Nasdaq
- Market Cap
- UBXG N/A
- HOTH 16.0M
- IPO Year
- UBXG 2024
- HOTH 2019
- Fundamental
- Price
- UBXG $3.23
- HOTH $1.43
- Analyst Decision
- UBXG
- HOTH Strong Buy
- Analyst Count
- UBXG 0
- HOTH 3
- Target Price
- UBXG N/A
- HOTH $4.00
- AVG Volume (30 Days)
- UBXG 5.5K
- HOTH 684.1K
- Earning Date
- UBXG 01-01-0001
- HOTH 05-12-2025
- Dividend Yield
- UBXG N/A
- HOTH N/A
- EPS Growth
- UBXG N/A
- HOTH N/A
- EPS
- UBXG N/A
- HOTH N/A
- Revenue
- UBXG $39,603,353.00
- HOTH N/A
- Revenue This Year
- UBXG N/A
- HOTH N/A
- Revenue Next Year
- UBXG N/A
- HOTH N/A
- P/E Ratio
- UBXG N/A
- HOTH N/A
- Revenue Growth
- UBXG N/A
- HOTH N/A
- 52 Week Low
- UBXG $2.36
- HOTH $0.58
- 52 Week High
- UBXG $567.04
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- UBXG N/A
- HOTH 61.94
- Support Level
- UBXG N/A
- HOTH $1.17
- Resistance Level
- UBXG N/A
- HOTH $1.57
- Average True Range (ATR)
- UBXG 0.00
- HOTH 0.10
- MACD
- UBXG 0.00
- HOTH 0.02
- Stochastic Oscillator
- UBXG 0.00
- HOTH 69.57
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).